Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gracure Pharmaceuticals is a research-driven pharmaceutical company headquartered in Delhi, India, specializing in the development and manufacturing of a diverse range of generic dosage forms. Established in 1992, the company operates a state-of-the-art manufacturing facility in Bhiwadi, Rajasthan, which holds prestigious certifications including EU-GMP, WHO-GMP, and PICS. Their product portfolio spans multiple therapeutic categories such as cardiovascular, gastrointestinal, anti-diabetic, and anti-infective treatments, offered in forms like tablets, capsules, and syrups. In addition to its own brand presence, Gracure is a significant player in the contract manufacturing (CMO/CDMO) space, serving global pharmaceutical partners. The company maintains a strong international footprint, exporting high-quality affordable medicines to markets across Europe, Southeast Asia, Africa, and Latin America. Gracure continues to invest in research and development to expand its portfolio of complex generics and maintain its competitive edge in the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gracure Pharmaceuticals.